Lynx1 Capital Management »

Pliant Therapeutics shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 1.8M 1.14

More positions owned by Lynx1 Capital Management

Cullinan Oncology (CGEM)
Stoke Therapeutics (STOK)
Agios Pharmaceuticals (AGIO)
C4 Therapeutics Com Stk (CCCC)
Korro Bio (KRRO)
Tscan Therapeutics (TCRX)
Precision Biosciences Com New (DTIL)
Neuphoria Therapeutics (NEUP)
Passage Bio Com New (PASG)
Cg Oncology (CGON)
Pliant Therapeutics (PLRX)
Entrada Therapeutics (TRDA)
Vyne Therapeutics (VYNE)
Traws Pharma Com New (TRAW)
Foghorn Therapeutics (FHTX)

View all positions for Lynx1 Capital Management

Top funds holding Pliant Therapeutics

Tang Capital Management
Citadel Advisors
ADAR1 Capital Management
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Renaissance Technologies
Monaco Asset Management SAM
Lynx1 Capital Management
Prosight Management
Woodline Partners
BML Capital Management
Peapod Lane Capital
Millennium Management
BlackRock

View all funds holding Pliant Therapeutics